chr18-31071603-AC-A
Position:
Variant summary
Our verdict is Pathogenic. Variant got 12 ACMG points: 12P and 0B. PVS1_ModeratePM2PP5_Very_Strong
The NM_024422.6(DSC2):c.2125+1delG variant causes a splice donor, intron change. The variant allele was found at a frequency of 0.00000205 in 1,460,652 control chromosomes in the GnomAD database, with no homozygous occurrence. 1/1 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Likely pathogenic (★★).
Frequency
Genomes: not found (cov: 32)
Exomes 𝑓: 0.0000021 ( 0 hom. )
Consequence
DSC2
NM_024422.6 splice_donor, intron
NM_024422.6 splice_donor, intron
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 4.30
Genes affected
DSC2 (HGNC:3036): (desmocollin 2) This gene encodes a member of the desmocollin protein subfamily. Desmocollins, along with desmogleins, are cadherin-like transmembrane glycoproteins that are major components of the desmosome. Desmosomes are cell-cell junctions that help resist shearing forces and are found in high concentrations in cells subject to mechanical stress. This gene is found in a cluster with other desmocollin family members on chromosome 18. Mutations in this gene are associated with arrhythmogenic right ventricular dysplasia-11, and reduced protein expression has been described in several types of cancer. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Feb 2015]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Pathogenic. Variant got 12 ACMG points.
PVS1
Splicing +-2 bp (donor or acceptor) variant, product NOT destroyed by NMD, known LOF gene, truncates exone, which is 0.0872136 fraction of the gene. Cryptic splice site detected, with MaxEntScore 4.3, offset of 44, new splice context is: aaaGTaact. Cryptic site results in frameshift change. If cryptic site found is not functional and variant results in exon loss, it results in inframe change.
PM2
Very rare variant in population databases, with high coverage;
PP5
Variant 18-31071603-AC-A is Pathogenic according to our data. Variant chr18-31071603-AC-A is described in ClinVar as [Likely_pathogenic]. Clinvar id is 199778.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr18-31071603-AC-A is described in Lovd as [Likely_pathogenic].
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
DSC2 | NM_024422.6 | c.2125+1delG | splice_donor_variant, intron_variant | ENST00000280904.11 | NP_077740.1 | |||
DSC2 | NM_004949.5 | c.2125+1delG | splice_donor_variant, intron_variant | NP_004940.1 | ||||
DSC2 | NM_001406506.1 | c.1696+1delG | splice_donor_variant, intron_variant | NP_001393435.1 | ||||
DSC2 | NM_001406507.1 | c.1696+1delG | splice_donor_variant, intron_variant | NP_001393436.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
DSC2 | ENST00000280904.11 | c.2125+1delG | splice_donor_variant, intron_variant | 1 | NM_024422.6 | ENSP00000280904.6 | ||||
DSC2 | ENST00000251081.8 | c.2125+1delG | splice_donor_variant, intron_variant | 1 | ENSP00000251081.6 | |||||
DSC2 | ENST00000648081.1 | c.1696+1delG | splice_donor_variant, intron_variant | ENSP00000497441.1 | ||||||
DSC2 | ENST00000682357.1 | c.1696+1delG | splice_donor_variant, intron_variant | ENSP00000507826.1 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 genomes
Cov.:
32
GnomAD4 exome AF: 0.00000205 AC: 3AN: 1460652Hom.: 0 Cov.: 31 AF XY: 0.00000138 AC XY: 1AN XY: 726756
GnomAD4 exome
AF:
AC:
3
AN:
1460652
Hom.:
Cov.:
31
AF XY:
AC XY:
1
AN XY:
726756
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome Cov.: 32
GnomAD4 genome
Cov.:
32
Bravo
AF:
ClinVar
Significance: Likely pathogenic
Submissions summary: Pathogenic:7Uncertain:1
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
Arrhythmogenic right ventricular dysplasia 11 Pathogenic:4
Likely pathogenic, no assertion criteria provided | clinical testing | Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen | - | - - |
Likely pathogenic, criteria provided, single submitter | clinical testing | Human Genome Sequencing Center Clinical Lab, Baylor College of Medicine | Jan 18, 2017 | This c.2125+1del variant has been reported in dbSNP (rs794728072) and ClinVar (RCV000181172.1). The frequency of this variant is unknown and this variant has not previously been observed in our patient cohort. This c.2125+1del variant affects the invariant acceptor splice site of intron 13 of the DSC2 gene. While not validated for clinical use, the computer-based algorithms predict this variant to disrupt the invariant donor splicing site. Loss of function variants including splicing site variants are disease-causing for this disorder. It is thus interpreted as a pathogenic variant. - |
Likely pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Oct 27, 2023 | This sequence change affects a splice site in intron 13 of the DSC2 gene. It is expected to disrupt RNA splicing. Variants that disrupt the donor or acceptor splice site typically lead to a loss of protein function (PMID: 16199547), and loss-of-function variants in DSC2 are known to be pathogenic (PMID: 23911551). This variant is not present in population databases (gnomAD no frequency). Disruption of this splice site has been observed in individual(s) with dilated cardiomyopathy and/or ventricular tachycardia (PMID: 28153106, 31931689, 33662488). ClinVar contains an entry for this variant (Variation ID: 199778). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic. - |
Likely pathogenic, criteria provided, single submitter | clinical testing | Institute of Human Genetics, University of Leipzig Medical Center | Nov 16, 2021 | _x000D_ Criteria applied: PVS1, PS4_MOD, PM2_SUP - |
not provided Pathogenic:2
Likely pathogenic, criteria provided, single submitter | clinical testing | GeneDx | Jan 27, 2025 | While this variant has been reported in studies exploring ARVC, these individuals either did not manifest symptoms of disease or it is unclear whether the individual(s) harboring this variant were clinically diagnosed with ARVC (PMID: 31638835, 28153106); Canonical splice site variant predicted to result in an in-frame loss of the adjacent exon in a gene for which loss of function is a known mechanism of disease; Not observed at significant frequency in large population cohorts (gnomAD); This variant is associated with the following publications: (PMID: 31447099, 28153106, 33662488, 31638835, 31931689) - |
Likely pathogenic, no assertion criteria provided | clinical testing | Genome Diagnostics Laboratory, University Medical Center Utrecht | - | - - |
Dilated cardiomyopathy 1A Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | Molecular Diagnostic Laboratory for Inherited Cardiovascular Disease, Montreal Heart Institute | Mar 14, 2019 | - - |
not specified Uncertain:1
Uncertain significance, flagged submission | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Nov 21, 2017 | Variant classified as Uncertain Significance - Favor Pathogenic. The c.2125+1del G variant in DSC2 has been reported in 1 individual with ARVC (Venlet 2017) and was absent from large population studies. This variant has also been reported in ClinVar (Variation ID 199778). The c.2125+1delG variant occurs in the invariant region (+/- 1,2) of the splice consensus sequence and is predicted to cause alt ered splicing leading to an abnormal or absent protein. Splice site and other lo ss of function variants in DSC2 have been reported in individuals with ARVC. In summary, while there is some suspicion for a pathogenic role, the clinical signi ficance of the c.2152+1delG variant is uncertain. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
DS_DG_spliceai
Position offset: 46
DS_DL_spliceai
Position offset: 2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at